Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/8866
|
| Title: | High incidences of Invasive Fungal Infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan |
| Authors: | Tang, JL;Kung, HC;Lei, WC;Yao, M;Wu, UI;Hsu, SC;Lin, CT;Li, CC;Wu, SJ;Hou, HA;Chou, WC;Huang, SY;Tsay, W;Chen, YC;Chen, YC;Chang, SC;Ko, BS;Tien, HF |
| Contributors: | Division of Infectious Diseases |
| Abstract: | Invasive fungal infections (IFIs) is an important complication for acute myeloid leukemia (AML) patients receiving induction chemotherapy. However, the epidemiological information is not clear in Southeastern Asia, an area of potential high incidences of IFIs. To clarify it, we enrolled 298 non-M3 adult AML patients receiving induction chemotherapy without systemic anti-fungal prophylaxis from Jan 2004 to Dec 2009, when we applied a prospective diagnostic and treatment algorithm for IFIs. Their demographic parameters, IFI characters, and treatment outcome were collected for analysis. The median age of these patients was 51 years. Standard induction chemotherapy was used for 246 (82.6%) patients, and 66.8% of patients achieved complete remission (CR) or partial remission. The incidence of all-category IFIs was 34.6% (5.7% proven IFIs, 5.0% probable IFIs and 23.8% possible IFIs). Candida tropicalis was the leading pathogen among yeast, and lower respiratory tract was the most common site for IFIs (75.4%, 80/106). Standard induction chemotherapy and failure to CR were identified as risk factors for IFIs. The presence of IFI in induction independently predicted worse survival (hazard ratio 1.536 (1.100-2.141), p value = 0.012). Even in those who survived from the initial IFI insults after 3 months, the presence of IFIs in induction still predicted a poor long-term survival. This study confirms high incidences of IFIs in Southeastern Asia, and illustrates potential risk factors; poor short-term and long-term outcomes are also demonstrated. This epidemiological information will provide useful perspectives for anti-fungal prophylaxis and treatment for AML patients during induction, so that best chances of cure and survival can be provided. |
| Date: | 2015-06 |
| Relation: | PLoS ONE. 2015 Jun;10(6):Article number e0128410. |
| Link to: | http://dx.doi.org/10.1371/journal.pone.0128410 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1932-6203&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000355979500080 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84936804320 |
| Appears in Collections: | [陳宜君] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB26061179.pdf | | 324Kb | Adobe PDF | 560 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
